Orchard Therapeutics plc - ADR

NASDAQ:ORTX   3:46:21 PM EDT
0.61
0.00 (+0.68%)
Earnings Announcements

Orchard Therapeutics Reports Q2 2022 Financial Results

Published: 08/04/2022 11:54 GMT
Orchard Therapeutics plc - ADR (ORTX) - Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights.
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights.
Orchard Therapeutics Plc- Ended Q2 With $170.9m of Cash and Investments and Runway Into 2024.
Orchard Therapeutics Plc - Qtrly Net Loss per Share, Basic and Diluted $0.40.
Revenue is expected to be $4.38 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $4.93 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.